AT-derived EVs benefit skeletal muscletrophism, protecting against ischemic degeneration and enhancing regeneration ina hindlimb ischemia model via increased MyoD, Myf5, and Pax7 expression[110]. The gene discussed is MYF5; the disease is ischemia.